The University of North Carolina at Chapel Hill is a clinical research site located in Chapel Hill, North Carolina, United States 27599.
Crixeo Clinical Trials Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.
The University of North Carolina at Chapel Hill has participated in 132 clinical trials with 34 currently active.
Therapeutic areas: Breast Cancer, Triple Negative Breast Cancer, PD-L1 Negative.
Sponsors: Dana-Farber Cancer Institute, Carelon Research, University of North Carolina, Chapel Hill.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in North Carolina · View every site in Chapel Hill
Trust Score: 80/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
The University of North Carolina at Chapel Hill has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The University of North Carolina at Chapel Hill has 132 clinical trials on record, with 34 currently active. Their work covers Breast Cancer, Triple Negative Breast Cancer, PD-L1 Negative.
The University of North Carolina at Chapel Hill has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.